A Computational Analysis of the Synergistic Effect of Coagulation Inhibitors on the Generation of Thrombin

The coagulation system (CS) is a complex, inter-connected biological system with major physiological and pathological roles. The CS may be viewed as a complex adaptive system, in which individual components are linked through multiple feedback and feedforward loops. The non-linear relationships between the numerous coagulation factors and the interplay among the elements of the CS render the study of this biology at a molecular and cellular level nearly impossible. We present an Agent Based Modeling and Simulation (ABMS) approach for simulating these complex interactions. Our ABMS approach utilizes a subset of 52 rules to define the interactions among 33 enzymes and factors of the CS. These rules simulate the interaction of each “agent”, such as substrates, enzymes, and cofactors, on a two-dimensional grid of ~12,000 cells and ~300,000 agents. Our ABMS method successfully reproduces the initiation, propagation, and termination of thrombin formation due to the activation of the extrinsic pathway. Furthermore, the ABMS is able to demonstrate the emergence of a threshold effect for thrombin generation as a result of the synergistic effect of combining anticoagulant systems.

[1]  Donghui Zhu,et al.  Mathematical modeling of blood coagulation cascade: kinetics of intrinsic and extrinsic pathways in normal and deficient conditions , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[2]  G. Broze,et al.  Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor* , 1998, The Journal of Biological Chemistry.

[3]  R. Kaufman,et al.  Model for the Factor VIIIa-dependent Decay of the Intrinsic Factor Xase , 1996, The Journal of Biological Chemistry.

[4]  H C Hemker,et al.  The role of phospholipids and factor Va in the prothrombinase complex. , 1980, The Journal of biological chemistry.

[5]  Gary An,et al.  Mathematical modeling in medicine: a means, not an end. , 2005, Critical care medicine.

[6]  K. Mann,et al.  Kinetics of human factor VII activation. , 1996, Biochemistry.

[7]  P. Mannucci,et al.  Screening Tests for Thrombophilic Patients: Which Tests, for Which Patient, by Whom, When, and Why? , 1998, Seminars in thrombosis and hemostasis.

[8]  K. Mann,et al.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation. , 1994, Journal of Biological Chemistry.

[9]  J Jesty,et al.  Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. , 1994, Biochemistry.

[10]  Kenneth G. Mann,et al.  Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II* , 1997, The Journal of Biological Chemistry.

[11]  W. Ruf,et al.  Role of Zymogen and Activated Factor X as Scaffolds for the Inhibition of the Blood Coagulation Factor VIIa-Tissue Factor Complex by Recombinant Nematode Anticoagulant Protein c2* , 2001, The Journal of Biological Chemistry.

[12]  J. McVey,et al.  Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). , 1994, Biochemistry.

[13]  G M Oosta,et al.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. , 1980, The Journal of biological chemistry.

[14]  Steven C Bankes,et al.  Agent-based modeling: A revolution? , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Furie,et al.  Mechanisms of thrombus formation. , 2008, The New England journal of medicine.

[16]  Timothy G Buchman,et al.  Nonlinear dynamics, complex systems, and the pathobiology of critical illness , 2004, Current opinion in critical care.

[17]  P. Fay,et al.  Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. , 1992, The Journal of biological chemistry.

[18]  P. Lollar,et al.  von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. , 1990, The Journal of biological chemistry.

[19]  H. Messmore,et al.  Hemostasis and Thrombosis: Basic Principles and Clinical Practice , 2001 .

[20]  D D Monkovic,et al.  Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.

[21]  V. V. van Hinsbergh,et al.  Extrinsic activation of human coagulation factors IX and X on the endothelial surface. , 1991, Thrombosis and haemostasis.

[22]  W Ruf,et al.  Exosite Interactions Determine the Affinity of Factor X for the Extrinsic Xase Complex* , 2000, The Journal of Biological Chemistry.

[23]  K. C. Jones,et al.  A Model for the Stoichiometric Regulation of Blood Coagulation* , 2002, The Journal of Biological Chemistry.

[24]  M. Panteleev,et al.  Mathematical models of blood coagulation and platelet adhesion: clinical applications. , 2007, Current pharmaceutical design.

[25]  P. Schoen,et al.  The in situ inhibition of prothrombinase-formed human alpha-thrombin and meizothrombin(des F1) by antithrombin III and heparin. , 1987, The Journal of biological chemistry.

[26]  R J Baugh,et al.  Role of the Activation Peptide Domain in Human Factor X Activation by the Extrinsic Xase Complex* , 1996, The Journal of Biological Chemistry.

[27]  P. Walsh,et al.  Kinetics of coagulation factor X activation by platelet-bound factor IXa. , 1990, Biochemistry.

[28]  K. Mann,et al.  Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. , 1993, The Journal of biological chemistry.

[29]  D. Wagner,et al.  The vessel wall and its interactions. , 2008, Blood.

[30]  S Krishnaswamy,et al.  The interaction of human factor VIIa with tissue factor. , 1992, The Journal of biological chemistry.

[31]  R E Rider Aspects of ulam: from cardinals to chaos. , 1989, Science.

[32]  S. Olson,et al.  Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence , 2001, The Journal of Biological Chemistry.

[33]  G An,et al.  Agent-based computer simulation and sirs: building a bridge between basic science and clinical trials. , 2001, Shock.

[34]  Kenneth G. Mann,et al.  Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin Generation , 1997, The Journal of Biological Chemistry.

[35]  Eric Bonabeau,et al.  Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T S Edgington,et al.  Macromolecular Substrate Affinity for the Tissue Factor-Factor VIIa Complex Is Independent of Scissile Bond Docking* , 1999, The Journal of Biological Chemistry.

[37]  P. Lollar,et al.  Coagulant properties of hybrid human/porcine factor VIII molecules. , 1992, The Journal of biological chemistry.

[38]  Dougald M Monroe,et al.  What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.